» Articles » PMID: 24044105

Korean Society for Sexual Medicine and Andrology (KSSMA) Guideline on Erectile Dysfunction

Overview
Date 2013 Sep 18
PMID 24044105
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In February 2011, the Korean Society for Sexual Medicine and Andrology (KSSMA) realized the necessity of developing a guideline on erectile dysfunction (ED) appropriate for the local context, and established a committee for the development of a guideline on ED. As many international guidelines based on objective evidence are available, the committee decided to adapt these guidelines for local needs instead of developing a new guideline. Considering the extensive research activities on ED in Korea, data with a high level of evidence among those reported by Korean researchers have been collected and included in the guideline development process. The latest KSSMA guideline on ED has been developed for urologists. The KSSMA hopes that this guideline will help urologists in clinical practice.

Citing Articles

Economic impact of reduced postoperative visits after inflatable penile prosthesis implantation.

Gill B, Shin Y, Durand K, Sun A, Babbar P, Rojanasarot S J Comp Eff Res. 2025; 14(3):e240204.

PMID: 39812079 PMC: 11864081. DOI: 10.57264/cer-2024-0204.


Management of Male Infertility with Coexisting Sexual Dysfunction: A Consensus Statement and Clinical Recommendations from the Asia-Pacific Society of Sexual Medicine (APSSM) and the Asian Society of Men's Health and Aging (ASMHA).

Chung E, Hui J, Xin Z, Kim S, Moon D, Yuan Y World J Mens Health. 2023; 42(3):471-486.

PMID: 37853539 PMC: 11216964. DOI: 10.5534/wjmh.230180.


Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation.

Rojanasarot S, Williams A, Edwards N, Khera M Sex Med. 2023; 11(2):qfad010.

PMID: 37082721 PMC: 10110759. DOI: 10.1093/sexmed/qfad010.


Consensus of Experts on the Treatment of Sexual Dysfunction after Surgery for Prostate Cancer in Taiwan.

Chen Y, Chang H, Huang W, Wang C, Hwang T, Liao C J Clin Med. 2023; 12(3).

PMID: 36769388 PMC: 9917785. DOI: 10.3390/jcm12030740.


Reaching consensus: a scoping review on erectile disorder guidelines.

Safaei M, Maasoumi R, Mahdavi S, Ghadirian L, Samadaee Gelehkolaee K J Med Life. 2022; 15(9):1074-1080.

PMID: 36415525 PMC: 9635228. DOI: 10.25122/jml-2022-0106.


References
1.
Greco E, Spera G, Aversa A . Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol. 2006; 50(5):940-7. DOI: 10.1016/j.eururo.2006.06.049. View

2.
Montorsi F, Guazzoni G, Strambi L, Da Pozzo L, Nava L, Barbieri L . Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997; 158(4):1408-10. View

3.
Ayyathurai R, Manoharan M, Nieder A, Kava B, Soloway M . Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int. 2008; 101(7):833-6. DOI: 10.1111/j.1464-410X.2007.07409.x. View

4.
Kloner R . Novel phosphodiesterase type 5 inhibitors: assessing hemodynamic effects and safety parameters. Clin Cardiol. 2004; 27(4 Suppl 1):I20-5. PMC: 6654137. DOI: 10.1002/clc.4960271306. View

5.
Kim B, Lim H, Chung J, Kim J, Lim K, Sohn D . Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. Br J Clin Pharmacol. 2008; 65(6):848-54. PMC: 2485225. DOI: 10.1111/j.1365-2125.2008.03107.x. View